Biosynthesis and distribution of leucocyte elastase inhibitor. Production of recombinant inhibitor.

The research focuses on the horse leucocyte elastase inhibitor (HLEI), a protein found in neutrophils, monocytes, and bone marrow cells. Scientists successfully synthesized this inhibitor using a new expression vector and proposed potential therapeutic benefits.

Understanding Leucocyte Elastase Inhibitor (HLEI)

• The study explores the origin and function of the HLEI, a cytoplasmic protein found in the body’s immune cells, such as neutrophils, monocytes, and bone marrow cells. Despite being present in these cells, the inhibitor isn’t released, not even when the cells are stimulated with substances that typically trigger an immune response.
• Scientists observed that while neutrophils didn’t express the inhibitor, monocytes and bone marrow appeared to create it efficiently.

Production of HLEI Using a Recombinant Approach

• The research team managed to produce a large amount of the HLEI using an expression vector called pREST5d. This method resulted in 88 milligrams of the inhibitor per 10 liters of E. coli culture.
• Following a two-step purification process, ion-exchange chromatography, and gel filtration, 36 mg of the purified recombinant inhibitor was yielded. The purity of the inhibitor was measured to be more than 95%, tested by SDS/PAGE (a common method for protein analysis).
• Further analysis showed that the recombinant protein was as effective as naturally occurring elastase inhibitors, inhibiting the process irreversibly.

Potential Therapeutic Implications

• The recombinant and natural HLEI proteins were removed from rat circulation at the same rate. This rapid removal, predominantly happening within the first 20 minutes, implies the protein has a short synergic half-life.
• This observation led to the suggestion that delivering HLEI directly to the lungs via aerosol could be a more effective form of therapy than intravenous injection. This is because the protein might stay put longer, which could be particularly beneficial in lung diseases where the elastase is causing damage.